Tectonic Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,917
Closed -$203K 329
2025
Q1
$203K Sell
2,917
-2,589
-47% -$214K 0.01% 312
2024
Q4
$474K Sell
5,506
-6
-0.1% -$649 0.03% 248
2024
Q3
$656K Buy
5,512
+340
+7% +$45.3K 0.04% 204
2024
Q2
$738K Buy
5,172
+603
+13% +$79.9K 0.05% 189
2024
Q1
$587K Hold
4,569
0.04% 204
2023
Q4
$473K Hold
4,569
0.04% 213
2023
Q3
$416K Buy
+4,569
New +$402K 0.04% 207

Other funds holding NVO

Tectonic Advisors's NVO Position: Q2 2025 in Review

Tectonic Advisors sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 2,917 shares — an estimated $203K sold.

Tectonic Advisors first reported a position in NVO in Q3 2023 and held it in 7 quarters. The position peaked at $738K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Tectonic Advisors reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Tectonic Advisors sold 2,917 Novo Nordisk shares in Q2 2025, an estimated $203K.
  • Tectonic Advisors first reported a position in Novo Nordisk in Q3 2023 and held it in 7 quarters.
  • Tectonic Advisors's Novo Nordisk position peaked at $738K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Tectonic Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.